Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Colorado State University
Zagazig University
Carevive Systems, Inc.
Carevive Systems, Inc.
Essen Biotech
University of Nebraska
Adela, Inc
Ohio State University Comprehensive Cancer Center
Mayo Clinic
AC Camargo Cancer Center
University Health Network, Toronto
Incyte Corporation
M.D. Anderson Cancer Center
IRCCS San Raffaele
University of Colorado, Denver
Arab American University (Palestine)
Washington University School of Medicine
University of Alabama at Birmingham
Baxter Healthcare Corporation
University of Alberta
Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León
Cedars-Sinai Medical Center
Universidade Federal de Pernambuco
Cyteir Therapeutics, Inc.
Taproot Health
University of Modena and Reggio Emilia
Cedars-Sinai Medical Center
Sanguine Biosciences
Cancer Support Community, Research and Training Institute, Philadelphia
OHSU Knight Cancer Institute
Incyte Corporation
Scripps Health
Weprom
GlaxoSmithKline
Novartis
Jonsson Comprehensive Cancer Center
Celgene
InSightec
University of Wisconsin, Madison
National Institutes of Health Clinical Center (CC)
LEO Pharma
AbbVie
Vanderbilt-Ingram Cancer Center
SWOG Cancer Research Network
City of Hope Medical Center
Incyte Corporation
CureOne